Michael Stibilj

Novotech Health Holdings engages in the development of contract research organization platform. The company was founded on October 12, 2020 and is headquartered in Australia.

Novotech Health Holdings Ltd. operates as a biotech-focused full-service contract research organization. Its integrated CRO platform provides clinical trial services ranging from consulting services prior to the commencement of the clinical phase to late-phase clinical trials. The firm’s services include: clinical trial services which include clinical research, bioequivalence and pharmacodynamics research, and drug development consulting services; and its related clinical trial services which include laboratory, site management organization, flexible insourcing and Phase I clinical trial unit services. The company was founded on February 25, 2020 and is headquartered in Singapore.

Protech Pharmaservices Corp. engages in the provision of clinical research and contract laboratory services, as well as sale of scientific instruments. Its services include bio analytical services, central laboratory services, early-phase clinical services, and late-phase clinical services. The company was founded on February 24, 1997 and is headquartered in Taipei, Taiwan.

Novotech (Australia) Pty Ltd. operates as a contract research organization. It provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services and central lab services. The firm offers patient recruitment and site selection, clinical operations and project management, medical and regulatory consulting, biometrics and data management solutions. The company was founded by Alek Safarian in 1996 and is headquartered in Sydney, Australia.

Novotech is a biotech specialist CRO with two operating brands, Novotech and PPC. The American company has over 1,765 FTEs working across its offices in 11 geographies in Asia-Pacific. Novotech provides drug development consulting and clinical development services across all phases, including labs, phase I facilities, and FDA regulatory expertise. The private company has experience in over 3,700 pre-clinical and clinical projects, including phase I to phase IV clinical trials and bioequivalence studies. Novotech is headquartered in Asia-Pacific and has subsidiaries in the United States. The company is internationally recognized as the leading centered biotech CRO with execution capabilities.